Amplexor is delighted to announce our official partnership with Averbis, to incorporate Averbis tools and services into the broader Amplexor Life Sciences solution suite. The alliance will help both companies target new markets worldwide.
This partnership demonstrates that advanced AI-based technologies can enable customers by supporting specific IDMP relevant use cases, improving the quality and efficiency of regulatory operations, reducing costs and accelerating time to market while maintaining full compliance. In future, these technologies will extend to areas beyond IDMP, further underlining the value of the partnership. Read the full partnership announcement here.